High-resolution analysis of chromosome arm 1p alterations in meningioma

Cancer Genetics and Cytogenetics

Volumn 120, Issue 1, 2000, Pages 30-36

  Bello, M Josefa ^a   De Campos, Jose M ^b   Vaquero, Jesus ^c   Kusak, M Elena ^b   Sarasa, Jose L ^d   Rey, Juan A ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b HOSPITAL UNIVERSITARIO RÍO HORTEGA   (Spain)

^c HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^d Dept of Anat Pathol of FJD ^*  (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; ARTICLE; CHROMOSOME 1P; CHROMOSOME 22; CHROMOSOME ANALYSIS; CONTROLLED STUDY; GENE DELETION; GENE LOCUS; GENETIC MARKER; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MENINGIOMA; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TUMOR SUPPRESSOR GENE;

BRAIN NEOPLASMS; CHROMOSOMES, HUMAN, PAIR 1; HUMANS; LOSS OF HETEROZYGOSITY; MENINGIOMA; MICROSATELLITE REPEATS;

EID: 0034237839     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(99)00249-6     Document Type: Article

References (41)

1. Miller D.C. Predicting recurrence of intracranial meningiomas. Neurosurg Clin North Am. 5:1994;193-200.
2. Kleihues P., Burger P.C., Scheitauer B.W. Histological Typing of Tumors of the Central Nervous System. International Histological Classification of Tumors. 2nd Ed:1993;Springer Verlag, Berlin, Heidelberg, New York.
3. Simon M., von Demising A., Larson J.J., Wellenreuther R., Kaskel P., Waha A., Warnick R.E., Tew J.M., Menon A.G. Allelic losses on chromosome 14, 10, and 1 in atypical and malignant meningiomas. a genetic model of meningioma progression Cancer Res. 55:1995;4696-4701.
4. Weber R.G., Boström J., Wolter M., Baudis M., Collins V.P., Reifemberger G., Lichter P. Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas. toward a genetic model of meningioma progression Proc Natl Acad Sci USA. 94:1997;14719-14724.
5. Leone P.E., Bello M.J., de Campos J.M., Vaquero J., Sarasa J.L., Pestaña A., Rey J.A. NF2 gene mutations and allelic status of 1p, 14q and 22q in sporadic meningiomas. Oncogene. 18:1999;2231-2239.
6. Ruttledge M.H., Sarrazin J., Rangaratnam S., Phelan C.M., Twist E., Merel P., Delattre O., Thomas G., Nordenskjöld M., Collins V.P., Dumanski J.P., Rouleau G.A. Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas. Nature Genet. 6:1994;180-184.
7. Rempel S.A., Schwechheimer K., Davis R.L., Cavenee W.K., Rosemblum M.L. Loss of heterozygosity for loci on chromosome 10 is associated with morphologically malignant meningioma progression. Cancer Res. 53:1993;2386-2392.
8. Lindblom A., Ruttledge M., Collins V.P., Nordenskjöld M., Dumanski J.P. Chromosomal deletions in anaplastic meningiomas suggest multiple regions outside chromosome 22 as important in tumor progression. Int J Cancer. 56:1994;354-357.
9. Bello M.J., de Campos J.M., Kusak M.E., Vaquero J., Sarasa J.L., Pestaña A., Rey J.A. Allelic loss at 1p is associated with tumor progression of meningiomas. Genes Chromosom Cancer. 9:1994;296-298.
10. Bello M.J., Leone P.E., Nebreda P., de Campos J.M., Kusak M.E., Vaquero J., Sarasa J.L., Garcia-Miguel P., Queizan A., Hernandez-Moneo J.L., Pestaña A., Rey J.A. Allelic status of chromosome 1 in neoplasms of the nervous system. Cancer Genet Cytogenet. 83:1995;160-164.
11. Menon A.G., Rutter J.L., von Sattel J.P., Synder H., Murdoch C., Blumenfeld A., Martuza R.L., von Deimling A., Gusella J.F., Houseal T.W. Frequent loss of chromosome 14 in atypical and malignant meningioma. identification of a putative tumor progression locus Oncogene. 14:1997;611-616.
12. Tse J.Y.M., Ng H.-K., Lau K.-M., Lo K.-W., Poon W.-S., Huang D.P. Loss of heterozygosity of chromosome 14q in low- and high-grade meningiomas. Hum Pathol. 28:1997;779-785.
13. Boström J., Mühlbauer A., Reifemberger G. Deletion mapping of the short arm of chromosome 1 identifies a common region of deletion distal to D1S496 in human meningiomas. Acta Neuropathol. 94:1997;479-485.
14. Sulman E.P., Dumanski J.P., White P.S., Zhao H., Maris J.M., Mathiesen T., Bruder C., Cnaan A., Brodeur G.M. Identification of a consistent region of allelic loss on 1p32 in meningiomas. correlation with increased morbidity Cancer Res. 58:1998;3226-3230.
15. Sambrook J., Fritsch E.F., Maniatis T. Molecular Cloning. A Laboratory Manual. 2nd Ed:1989;Cold Spring Harbor Laboratory Press, New York.
16. Rey J.A., Bello M.J., Jimenez Lara A., Vaquero J., Kusak M.E., de Campos J.M., Sarasa J.L., Pestaña A. Loss of heterozygosity for distal markers on 22q in human gliomas. Int J Cancer. 51:1992;703-706.
17. Bender B., Wiestler O.D., von Deimling A. A device for processing large acrylamide gels. Biotechniques. 16:1994;204-206.
18. Canzian F., Salovaara R., Hemminki A., Kristo P., Chadwick R.B., Aaltonen L.A., de la Chapelle A. Semiautomated assessment of loss of heterozygosity and replication error in tumors. Cancer Res. 56:1996;3331-3337.
19. Pineau P., Nagai H., Prigent S., Wei Y., Gyapay G., Weissenbach J., Tiollais P., Buendia M.-A., Dejean A. Identification of three distinct regions of allelic deletions on the short arm of chromosome 8 in hepatocellular carcinoma. Oncogene. 18:1999;3127-3134.
20. Rey J.A., Bello M.J., de Campos J.M., Vaquero J., Kusak M.E., Sarasa J.L., Pestaña A. Abnormalities of chromosome 22 in human brain tumors determined by combined cytogenetic and molecular genetic approaches. Cancer Genet Cytogenet. 66:1993;1-10.
21. Rey J.A., Bello M.J., de Campos J.M., Kusak M.E., Moreno S. Chromosomal involvement secondary to -22 in human meningiomas. Cancer Genet Cytogenet. 33:1988;275-290.
22. Casartelli C., Rogatto S.R., Neto J.B. Karyotypic evolution of human meningioma. Progression through malignancy. Cancer Genet Cytogenet. 40:1989;33-45.
23. Vagner-Capodano A.M., Grisoli F., Gambarelli D., Sedan R., Pellet W., de Victor B. Correlation between cytogenetic and histopathological findings in 75 human meningiomas. Neurosurgery. 32:1993;892-900.
24. Griffin C.A., Hrubar R.H., Long P.P., Miller N., Volz P., Canson B., Brem H. Chromosome abnormalities in meningeal neoplasms. do they correlate with histology Cancer Genet Cytogenet. 78:1994;46-52.
25. Lekanne Deprez R.H., Riegman P.H., van Drunen E., Warring U.L., Groen N.A., Stefanko S.Z., Koper J.W., Avezaat C.J.J., Mulder P.G.H., Zwarthoff E.C., Hagemeijer A. Cytogenetic, molecular genetic and pathological analyses in 126 meningiomas. J Neuropathol Exp Neurol. 54:1995;224-235.
26. Henn W., Cremerius U., Heide G., Lippitz B., Schröder J.M., Gilsbach J.M., Büll U., Zang K.D. Monosomy 1p is correlated with enhanced in vivo glucose metabolism in meningiomas. Cancer Genet Cytogenet. 79:1995;144-148.
27. Lopez-Gines C., Cerda-Nicolas M., Barcia-Salorio J.L., Llombart-Boschm A. Cytogenetical findings of recurrent meningiomas. A study of 10 tumors. Cancer Genet Cytogenet. 85:1995;113-117.
28. Perry A., Jenkins R.B., Dahl R.J., Moertel C.A., Scheitauer B.W. Cytogenetic analysis of aggressive meningiomas. Possible diagnostic and prognostic implications. Cancer. 77:1996;2567-2573.
29. Maruno M., Yoshimine T., Muhammad A.K.M.G., Ninomiya H., Hayakawa T. Chromosomal losses and gains in meningiomas. comparative genomic hybridization (CGH) study of the whole genome Neurol Res. 20:1998;612-616.
30. Bièche I., Khodja A., Lidereau R. Deletion mapping of chromosomal region 1p32-pter in primary breast cancer. Genes Chromosom Cancer. 24:1999;255-263.
31. Kaghad M., Bonnet H., Yang A., Creancier L., Biscan J.C., Valent A., Minty A., Chalon P., Lelias J.M., Dumont X., Ferrara P., McKeon F., Caput D. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell. 90:1997;809-819.
32. Versteeg R., Caron H., Cheng N.C., van der Drift P., Slater R., Westerveld A., Voute P.A., Delattre O., Laureys G., Van Roy N., Speleman F. 1p36. Every subband a suppressor? Eur J Cancer. 31A:1995;538-541.
33. Caron H., Peter M., van Sluis P., Speleman F., de Kraker J., Laureys G., Michon J., Brugières L., Voute P.A., Westerveld A., Slater R., Delattre O., Versteeg R. Evidence for two tumour suppressor loci on chromosomal bands 1p35-36 involved in neuroblastoma. one probably imprinted, another associated with N-myc amplification Hum Mol Genet. 4:1995;535-539.
34. Niedermayer I., Feiden W., Henn W., Steilen-Gimbel H., Steudel W.I., Zang K.D. Loss of alkaline phosphatase activity in meningiomas. a rapid histochemical technique indicating progression-associated deletion of a putative tumor suppressor gene on the distal part of the short arm of chromosome 1 J Neuropathol Exp Neurol. 56:1997;879-886.
35. Rasio D., Marakumo Y., Robbins D., Roth T., Silver A., Negrini M., Schmidt C., Burczak J., Fishel R., Croce C.M. Characterization of the human homologue of RAD54. a gene located on 1p32 at a region of high loss of heterozygosity in breast tumors Cancer Res. 57:1997;2378-2383.
36. Bello M.J., de Campos J.M., Vaquero J., Ruiz-Barnes P., Kusak M.E., Sarasa J.L., Rey J.A. hRAD54 gene and 1p high resolution deletion mapping analyses in oligodendrogliomas. Cancer Genet Cytogenet. 116:2000;142-147.
37. Mendiola M., Bello M.J., Alonso J., Leone P.E., Vaquero J., Sarasa J.L., Kusak M.E., de Campos J.M., Pestaña A., Rey J.A. Search for mutations of the hRAD54 gene in sporadic meningiomas with deletion at 1p32. Mol Carcinog. 24:1999;300-304.
38. Reifenberger J., Reifenberger G., Liu L., James C.D., Wechsler W., Collins V.P. Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p. Am J Pathol. 145:1994;1175-1190.
39. Bello M.J., Leone P.E., Vaquero J., de Campos J.M., Kusak M.E., Sarasa J.L., Pestaña A., Rey J.A. Allelic loss at 1p and 19q frequently occurs in association and may represent early oncogenic events in oligodendroglial tumors. Int J Cancer. 64:1995;207-210.
40. Kraus J.A., Koopmann J., Kaskel P., Maintz D., Brandner S., Schramm J., Louis D.N., Wiestler O.D., von Deimling A. Shared allelic losses on chromosomes 1p and 19q suggest a common origin of oligodendroglioma and oligoastrocytoma. J Neuropathol Exp Neurol. 54:1995;91-95.
41. Takayama H., Suzuki T., Mugishima H., Fujisawa T., Ookuni M., Schwab M., Gehring M., Nakamura Y., Sugimura T., Tereda M., Yokota J. Deletion mapping of chromosomes 14q and 1p in human neuroblastoma. Oncogene. 7:1992;1185-1189.